Literature DB >> 1701284

Proliferative potential of human brain tumours as assessed by nucleolar organizer regions (AgNORs) and Ki67-immunoreactivity.

K H Plate1, J Rüschoff, J Behnke, H D Mennel.   

Abstract

Two proliferation markers, silver stained nucleolar organizer regions (AgNOR) and immunoreactivity with Ki-67, were used to assess the proliferative activity in 80 smear preparations from neurosurgically removed intracranial tumours. These included 45 gliomas, 18 meningiomas, 8 metastases and 9 others. We found a remarkably close correlation between the results obtained with both methods. Increasing malignancy, as determined by conventional grading, was paralleled by an increase in the growth fraction and the number of nucleolar organizer regions. Linear regression analysis yielded the following equation: AgNORs/cell = 0.35 x L1 (Ki-67) + 3.24, with a correlation coefficient of rs = 0.53 (Spearman rank correlation test, p less than 0.0001). Thus, both the Ki-67 L1 and the AgNOR technique appear suitable for estimating the proliferative potential in smear preparations of human intracranial neoplasms. The AgNOR technique may be particularly useful for application to stereotaxic biopsies since it can easily be performed on minute tumour samples.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1701284     DOI: 10.1007/bf01842827

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  31 in total

1.  Application of the AgNOR method to cell imprints.

Authors:  J Rüschoff; K H Plate; A Bittinger
Journal:  J Pathol       Date:  1989-08       Impact factor: 7.996

2.  The use of the monoclonal antibody Ki-67 in the identification of proliferating cells: application to surgical neuropathology.

Authors:  P C Burger; T Shibata; P Kleihues
Journal:  Am J Surg Pathol       Date:  1986-09       Impact factor: 6.394

3.  Location of ribosomal DNA in the human chromosome complement.

Authors:  A S Henderson; D Warburton; K C Atwood
Journal:  Proc Natl Acad Sci U S A       Date:  1972-11       Impact factor: 11.205

Review 4.  At the heart of the nucleolus.

Authors:  G Jordan
Journal:  Nature       Date:  1987 Oct 8-14       Impact factor: 49.962

5.  An improved technique for selective silver staining of nucleolar organizer regions in human chromosomes.

Authors:  S E Bloom; C Goodpasture
Journal:  Hum Genet       Date:  1976-10-28       Impact factor: 4.132

6.  The monoclonal antibody Ki-67 as a marker for proliferating cells in stereotactic biopsies of brain tumours.

Authors:  C B Ostertag; B Volk; T Shibata; P Burger; P Kleihues
Journal:  Acta Neurochir (Wien)       Date:  1987       Impact factor: 2.216

7.  Proliferative potential of meningiomas determined with the monoclonal antibody Ki-67.

Authors:  W Roggendorf; T Schuster; J Peiffer
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

8.  In situ cell kinetics studies on human neuroectodermal tumors with bromodeoxyuridine labeling.

Authors:  T Hoshino; T Nagashima; J A Murovic; C B Wilson; M S Edwards; P H Gutin; R L Davis; S J DeArmond
Journal:  J Neurosurg       Date:  1986-03       Impact factor: 5.115

9.  Identification of proliferating cells in human gliomas using the monoclonal antibody Ki-67.

Authors:  P Zuber; M F Hamou; N de Tribolet
Journal:  Neurosurgery       Date:  1988-02       Impact factor: 4.654

10.  Nucleolar silver-stained granules in maturing erythroid and granulocytic cells.

Authors:  K Smetana; Z Likovský
Journal:  Cell Tissue Res       Date:  1984       Impact factor: 5.249

View more
  11 in total

1.  Argyrophilic nucleolar organizer region counts in multiple myeloma: a histopathological study on bone marrow trephine biopsies.

Authors:  A Pich; L Chiusa; F Marmont; N Cappello; R Navone
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

2.  Recurrence of meningiomas versus proliferating cell nuclear antigen (PCNA) positivity and AgNOR counting.

Authors:  E Demirtaş; F Yilmaz; I Ovül; K Oner
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

3.  Proliferating cell nuclear antigen expression in central nervous system neoplasms.

Authors:  A Allegranza; S Girlando; G L Arrigoni; S Veronese; F A Mauri; M Gambacorta; B Pollo; P Dalla Palma; M Barbareschi
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

4.  Stabilization of c-myc protein in human glioma cells.

Authors:  H Shindo; E Tani; T Matsumuto; T Hashimoto; J Furuyama
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

Review 5.  Techniques to assess the proliferative potential of brain tumors.

Authors:  Alfredo Quiñones-Hinojosa; Nader Sanai; Justin S Smith; Michael W McDermott
Journal:  J Neurooncol       Date:  2005-08       Impact factor: 4.130

6.  Proliferating cell nuclear antigen immunoreactivity in human central nervous system neoplasms.

Authors:  E Karamitopoulou; E Perentes; M Melachrinou; T Maraziotis
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

7.  Regional differences in bromodeoxyuridine uptake, expression of Ki-67 protein, and nucleolar organizer region counts in glioblastoma multiforme.

Authors:  K Onda; R L Davis; C B Wilson; T Hoshino
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

8.  The growth potential of ependymomas with varying grades of malignancy measured by the Ki-67 labelling index and mitotic index.

Authors:  R Schröder; C Ploner; R I Ernestus
Journal:  Neurosurg Rev       Date:  1993       Impact factor: 3.042

9.  Ki-67 immunoreactivity in human central nervous system tumors: a study with MIB 1 monoclonal antibody on archival material.

Authors:  E Karamitopoulou; E Perentes; I Diamantis; T Maraziotis
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

10.  MDM2 and p53 expression in gliomas: a multivariate survival analysis including proliferation markers and epidermal growth factor receptor.

Authors:  P Korkolopoulou; P Christodoulou; K Kouzelis; M Hadjiyannakis; A Priftis; G Stamoulis; A Seretis; E Thomas-Tsagli
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.